Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations

WAF1, a potential mediator of p53 tumor suppression

Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu et al. · Cell · 1993 · 8.4K citations

Life Sciences, Genetics, Molecular Biology +13

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

NL Harris, ES Jaffe, H Stein et al. · Blood · 1994 · 6.4K citations · Full text

Veterinary Medicine, Oncology, Pathology +14

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

J L Cordell, Brunangelo Falini, Wendy N. Erber et al. · Journal of Histochemistry & Cytochemistry · 1984 · 3.2K citations

Medicine, Biochemistry, Pathology +17

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma

Blood · 1997 · 2.5K citations · Full text

Medicine, Oncology, Pathology +11

A p16 ^INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma

Thomas Wölfel, Martina Hauer, Jörg Schneider et al. · Science · 1995 · 1.1K citations

Medicine, Immunology, Oncology +17